Cargando…
Endovascular Renal Denervation in End-Stage Kidney Disease Patients: Cardiovascular Protection—A Proof-of-Concept Study
INTRODUCTION: Sympathetic neural activation is markedly increased in end-stage kidney disease (ESKD). Catheter-based renal denervation (RDN) reduces sympathetic overactivity and blood pressure in resistant hypertension. We investigated the effect of RDN on sympathetic neural activation and left vent...
Autores principales: | Hoye, Neil A., Wilson, Luke C., Wilkins, Gerard T., Jardine, David L., Putt, Tracey L., Samaranayaka, Ari, Schollum, John B.W., Walker, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733679/ https://www.ncbi.nlm.nih.gov/pubmed/29270493 http://dx.doi.org/10.1016/j.ekir.2017.04.012 |
Ejemplares similares
-
Endovascular renal denervation: a novel sympatholytic with relevance to chronic kidney disease
por: Hoye, Neil A., et al.
Publicado: (2014) -
Health-Related Quality of Life and Disability Among Older New
Zealanders With Kidney Failure: A Prospective Study
por: Butcher, Elizabeth, et al.
Publicado: (2022) -
Predictors of Health Deterioration Among Older New Zealanders Undergoing Dialysis: A Three-Year Accelerated Longitudinal Cohort Study
por: Shettigar, Reshma, et al.
Publicado: (2021) -
Metformin doses to ensure efficacy and safety in patients with reduced kidney function
por: Kuan, Isabelle H. S., et al.
Publicado: (2021) -
Recruitment and participant baseline characteristics in the dialysis outcomes in those aged 65 years or older study
por: McNoe, Bronwen, et al.
Publicado: (2019)